Free tool
Diagnostics stocks
We cover 69 companies grouped under the Diagnostics theme. The median market value in the group is $28.91M. Across the group, the median move over the past trading day is −0.27%. 37% of the 68 with a 200-day average trade above it. Price change over the past year runs from −83.9% to +61.5% across the middle 80 percent of the group, with a median of −16.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
69 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| 7V0.DE | Novogenia AG | $89.54M | Micro cap | −25.00% |
| 6678.T | Techno Medica Co., Ltd. | $88.35M | Micro cap | +12.34% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.57M | Micro cap | −52.03% |
| BB1.AX | BLINKLAB FPO [BB1] | $86.46M | Micro cap | +47.22% |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% |
| MDXH | MDxHealth SA | $72.15M | Micro cap | −84.51% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $67.22M | Micro cap | −25.93% |
| DXR | Daxor Corporation | $58.53M | Micro cap | −11.60% |
| ALKLH.PA | Klea Holding SA | $54.74M | Micro cap | −32.00% |
| CYC.AX | Cyclopharm Limited | $46.72M | Micro cap | −48.30% |
| BIOBV.HE | Biohit Oyj | $46.63M | Micro cap | −8.13% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| PAVM | PAVmed Inc. | $42.54M | Micro cap | −63.21% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| 2385.T | Soiken Holdings Inc. | $36.93M | Micro cap | +17.28% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| COV.AX | Cleo Diagnostics Ltd | $35.81M | Micro cap | +4.48% |
| ACARIX.ST | Acarix AB (publ) | $32.23M | Micro cap | −14.11% |
| NXN.AX | Nexsen Ltd | $30.21M | Micro cap | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | $30.10M | Micro cap | +27.08% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| MAP.AX | Microba Life Sciences Limited | $27.68M | Micro cap | −42.11% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| ALIKO.PA | Ikonisys S.A. | $26.94M | Micro cap | −6.58% |
| RHY.AX | Rhythm Biosciences Limited | $25.43M | Micro cap | 0.00% |
| 6090.T | Human Metabolome Technologies, Inc. | $21.19M | Micro cap | −16.38% |
| PIQ.AX | Proteomics International Laboratories Ltd | $19.61M | Micro cap | −48.44% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| URT.WA | Urteste S.A. | $17.98M | Micro cap | −15.31% |
| BDX.AX | BCAL Diagnostics Limited | $17.70M | Micro cap | −6.25% |
| IIQ.AX | INOVIQ Ltd | $17.65M | Micro cap | −58.54% |
| GMT.WA | Genomtec S.A. | $17.34M | Micro cap | −40.65% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| TRI.AX | TrivarX Limited | $13.27M | Micro cap | +60.00% |
| BOUL.ST | Boule Diagnostics AB (publ) | $12.76M | Micro cap | −47.36% |
| BMX.WA | BioMaxima S.A. | $11.52M | Micro cap | −20.78% |
| AT1.AX | Atomo Diagnostics Limited | $11.03M | Micro cap | −5.56% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.78M | Micro cap | −88.08% |
| CODX | Co-Diagnostics, Inc. | $8.73M | Micro cap | −87.22% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| AIDX | 20/20 Biolabs, Inc. | $7.19M | Micro cap | −97.64% |
| ACON | Aclarion, Inc. | $6.89M | Micro cap | −66.10% |
| OBD.L | Oxford BioDynamics Plc | $6.85M | Micro cap | −74.11% |
| INBS | Intelligent Bio Solutions Inc. | $6.84M | Micro cap | −85.79% |
| IBX.AX | Imagion Biosystems Limited | $5.74M | Micro cap | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.71M | Micro cap | −48.46% |
| BMRA | Biomerica, Inc. | $5.22M | Micro cap | −46.35% |
| ALPRE.PA | Predilife S.A. | $5.10M | Micro cap | −65.74% |
| REVB | Revelation Biosciences, Inc. | $3.80M | Micro cap | −91.25% |
| ONCO | Onconetix, Inc. | $2.54M | Micro cap | −99.56% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| BJDX | Bluejay Diagnostics, Inc. | $924.41K | Micro cap | −83.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.